Phase 2 Open-Label, Multicenter, Single-Arm Study of Cemiplimab in Patients with Locally Advanced Basal Cell Carcinoma after Hedgehog Inhibitor Therapy: Extended Follow-Up
Journal of the American Academy of Dermatology（2023）
关键词
cemiplimab,clinical trial,hedgehog inhibitor,immune checkpoint inhibitor,locally advanced basal cell carcinoma,phase 2,quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要